command alkon.jpg
Dallas, Texas is the Home of Command Alkon’s Annual Spring TRAININGDAYS
18 févr. 2020 10h06 HE | Command Alkon
BIRMINGHAM, Ala., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Command Alkon, the leading Supplier Collaboration Platform for Construction’s Heavy Work, will offer their annual Spring TRAININGDAYS Regional...
integra_resources_logo.jpg
Integra Reports on Positive Metallurgical Test-work Program Ongoing at DeLamar and Florida Mountain Deposits
08 avr. 2019 06h00 HE | Integra Resources Corp.
Press Release Highlights: Oxidation boundaries on the NI 43-101 inferred resource estimate at DeLamar and Florida Mountain are estimated at:• 24% oxide mineralization• 29% transitional...
Unknown.png
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
05 févr. 2019 07h50 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will...
Unknown.png
Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019
20 déc. 2018 07h50 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will...
Unknown.png
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
17 déc. 2018 07h50 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Unknown.png
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
06 déc. 2018 07h50 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Unknown.png
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court
04 déc. 2018 07h50 HE | Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
integra_resources_logo.jpg
Integra Resources Intersects 1.41 g/t AuEq Over 144.78 m, incl 12.69 g/t AuEq Over 9.15 m at Delamar Deposit, Extends Sullivan Gulch Zone by 250 m in Step-Out Drilling
18 sept. 2018 06h00 HE | Integra Resources Corp.
Press Release Highlights: Results from both step-out and infill drilling continues to confirm gold-silver mineralization continuity and future resource expansion potential to the southeast of...
integra_resources_logo.jpg
Integra Resources Intercepts 2.16 g/t AuEq Over 220.98 m, Including 4.14 g/t AuEq Over 73.15 m, and 1.74 g/t AuEq Over 198.12 m in Expansion Drill Program at the DeLamar Project
25 juin 2018 04h00 HE | Integra Resources Corp.
Press Release Highlights: Drilling continues to intersect mineralization beyond the footprint of the DeLamar Deposit to the southeast (“SE”) of previously reported results, almost no drilling has...
integra_resources_logo.jpg
Integra Resources Commences 20,000 Meter Drill Program at the DeLamar Project
13 févr. 2018 06h00 HE | Integra Resources Corp.
News Release Highlights: Integra Resources commences the first drill program on the DeLamar Gold-Silver Project in 25 yearsPhase one of drilling on the DeLamar Deposit increased to 6,000 meters...